First in Human Single Ascending Dose Study of MOR107

NCT03067363 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

INDUSTRY

Sponsor class

Stopped Part 1 completed successfully. Part 2 not conducted.

Conditions

Safety

Interventions

DRUG: MOR107
DRUG: Placebo
OTHER: Low sodium diet

Sponsor

Alan Richardson

Collaborators

[object Object]